1. Home
  2. SGRP vs AYTU Comparison

SGRP vs AYTU Comparison

Compare SGRP & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.82

Market Cap

20.5M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.66

Market Cap

23.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRP
AYTU
Founded
1967
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
23.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SGRP
AYTU
Price
$0.82
$2.66
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
67.6K
135.0K
Earning Date
11-14-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,130,000.00
$63,696,000.00
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
$47.32
P/E Ratio
N/A
N/A
Revenue Growth
21.79
N/A
52 Week Low
$0.76
$0.95
52 Week High
$2.10
$3.07

Technical Indicators

Market Signals
Indicator
SGRP
AYTU
Relative Strength Index (RSI) 43.18 56.52
Support Level $0.77 $2.60
Resistance Level $0.92 $2.87
Average True Range (ATR) 0.04 0.16
MACD 0.00 -0.01
Stochastic Oscillator 41.92 34.23

Price Performance

Historical Comparison
SGRP
AYTU

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: